1. Home
  2. TWST vs WLYB Comparison

TWST vs WLYB Comparison

Compare TWST & WLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWST
  • WLYB
  • Stock Information
  • Founded
  • TWST 2013
  • WLYB 1807
  • Country
  • TWST United States
  • WLYB United States
  • Employees
  • TWST N/A
  • WLYB N/A
  • Industry
  • TWST Biotechnology: Biological Products (No Diagnostic Substances)
  • WLYB Books
  • Sector
  • TWST Health Care
  • WLYB Consumer Discretionary
  • Exchange
  • TWST Nasdaq
  • WLYB Nasdaq
  • Market Cap
  • TWST 2.3B
  • WLYB 2.1B
  • IPO Year
  • TWST 2018
  • WLYB N/A
  • Fundamental
  • Price
  • TWST $25.76
  • WLYB $39.85
  • Analyst Decision
  • TWST Buy
  • WLYB
  • Analyst Count
  • TWST 9
  • WLYB 0
  • Target Price
  • TWST $50.67
  • WLYB N/A
  • AVG Volume (30 Days)
  • TWST 1.6M
  • WLYB 178.0
  • Earning Date
  • TWST 08-04-2025
  • WLYB 09-04-2025
  • Dividend Yield
  • TWST N/A
  • WLYB 3.63%
  • EPS Growth
  • TWST N/A
  • WLYB N/A
  • EPS
  • TWST N/A
  • WLYB 1.78
  • Revenue
  • TWST $362,273,000.00
  • WLYB $1,670,600,000.00
  • Revenue This Year
  • TWST $22.28
  • WLYB $1.45
  • Revenue Next Year
  • TWST $17.40
  • WLYB $2.70
  • P/E Ratio
  • TWST N/A
  • WLYB $21.07
  • Revenue Growth
  • TWST 22.72
  • WLYB N/A
  • 52 Week Low
  • TWST $24.28
  • WLYB $37.27
  • 52 Week High
  • TWST $55.33
  • WLYB $52.90
  • Technical
  • Relative Strength Index (RSI)
  • TWST 36.12
  • WLYB 39.69
  • Support Level
  • TWST $24.97
  • WLYB $39.63
  • Resistance Level
  • TWST $27.29
  • WLYB $42.70
  • Average True Range (ATR)
  • TWST 1.23
  • WLYB 0.02
  • MACD
  • TWST 0.10
  • WLYB 0.09
  • Stochastic Oscillator
  • TWST 20.73
  • WLYB 70.97

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.

About WLYB John Wiley & Sons Inc.

John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

Share on Social Networks: